Daniel P Gray

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
A comparison is made between the expenditure during the last 90 days of life on 98 terminal cancer patients cared for by a home based hospice service and that on matched patients dying without the home hospice service. The control patients were matched for site of primary cancer, age and sex. The individual records of both groups of patients were analyzed(More)
OBJECTIVE To analyse survival trends and regional variation for very preterm infants admitted to neonatal care. SETTING All neonatal units in England. PATIENTS Infants born at 22+0-31+6 weeks+daysgestational age (GA) over 2008-2014 and admitted to neonatal care; published data for admitted infants 22+0-25+6 weeks+days GA in 1995 and 2006, and for live(More)
OBJECTIVES To report on retinopathy of prematurity (ROP) screening compliance against a national guideline, factors associated with non-compliance and effect on ROP treatment. DESIGN National cohort study using operational NHS data from the National Neonatal Research Database (NNRD) for the period 2009-2011. SETTING 161 (94%) neonatal units in England.(More)
The purpose of this study was to examine the combined effects of oral contraceptive (OC) use and strenuous exercise on the lipid profiles of a group of 11 women runners. The five runners who used OCs had lipid profiles within normal ranges. When compared with a group of six runners who were not using OCs, matched for body fat and cholesterol intake, no(More)
The combination of 2'-deoxycoformycin (DCF), a potent adenosine deaminase (ADA) inhibitor, and 9-beta-D-arabinofuranosyladenine (Ara-A) was used in a patient with acute nonlymphocytic leukemia refractory to all conventional modes of therapy. DCF was given by periodic iv injections to ablate ADA activity. Ara-A was given by continuous iv infusion at an(More)
BACKGROUND On the basis of a small number of case studies, IV propofol has been advocated for the treatment of chronic daily headache (CDH). There has been no randomized controlled trial of this therapy. Our objective in this randomized, double-blind, placebo-controlled trial was to determine whether a single IV dose of propofol 2.4 mg/kg results in(More)
  • 1